ALISO VIEJO, Calif.--(BUSINESS WIRE)--Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, announced today that it has entered into an agreement with the University of Pennsylvania School of Medicine’s Flow Cytometry and Cell Sorting Resource Laboratory (Flow Cytometry Lab) for a multilevel educational and technical training program. This innovative program is intended to provide the technical and professional staff at Clarient with the necessary skills to provide superior clinical service using both standard and non-standard assays.
